<DOC>
	<DOCNO>NCT00008008</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy work different way stop tumor cell divide stop grow die . Giving chemotherapy peripheral stem cell bone marrow transplant may allow doctor give high dos chemotherapy drug kill tumor cell . PURPOSE : This phase II trial study well thiotepa follow peripheral stem cell bone marrow transplant work treat patient malignant glioma .</brief_summary>
	<brief_title>Thiotepa Followed Peripheral Stem Cell Bone Marrow Transplant Treating Patients With Malignant Glioma</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate , disease-free interval , overall survival patient malignant glioma treat high-dose thiotepa follow autologous peripheral blood stem cell transplantation . - Determine toxicity regimen patient . - Determine pharmacokinetics regimen patient . - Determine whether drug enters cerebrospinal fluid patient . OUTLINE : Following course induction chemotherapy cyclophosphamide IV 4 hour , patient receive filgrastim ( G-CSF ) daily completion peripheral blood stem cell ( PBSC ) harvesting . PBSCs collect 3-5 day . Patients mobilize sufficient cell undergo bone marrow harvest . Patients receive high-dose thiotepa IV 5 hour day -2 . PBSCs bone marrow reinfused day 0 . Patients receive sargramostim ( GM-CSF ) subcutaneously daily begin day 0 continue blood count recover . Treatment repeat every 2-3 week total 1-4 course absence disease progression unacceptable toxicity . Quality life assess baseline , every course , monthly 6 month , every 2 month thereafter . Patients follow monthly 6 month every 2 month thereafter . PROJECTED ACCRUAL : A total 5-40 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Ependymoma</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignant glioma Primary recurrent glioblastoma multiforme ( include gliosarcoma ) follow surgery radiotherapy prior conventional chemotherapy ( e.g. , carmustine procarbazine , vincristine , lomustine ) Recurrent refractory anaplastic astrocytoma follow prior therapy ( must chemoresistant ) Recurrent refractory ependymoma primitive neuroectodermal tumor ( PNET ) follow prior therapy Recurrent refractory oligodendroglioma oligoastrocytoma follow prior therapy ( must chemoresistant ) Evaluable disease gadoliniumenhanced MRI Ineligible high priority national institutional study ( e.g. , protocol CAMP004 ) PATIENT CHARACTERISTICS : Age : Any age Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Creatinine le 1.5 time normal Cardiovascular : LVEF least 45 % MUGA Pulmonary : DLCO least 60 % predict OR Approval pulmonologist Other : Not pregnant nursing Fertile patient must use effective contraception HIV negative PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No concurrent chemotherapy Endocrine therapy : No concurrent anticancer hormonal therapy No concurrent steroid antiemetic Radiotherapy : See Disease Characteristics See Surgery Surgery : See Disease Characteristics For patient glioblastoma multiforme , concurrent surgery and/or stereotactic radiosurgery reduce tumor bulk allow Other : No concurrent acetaminophen chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>childhood high-grade cerebral astrocytoma</keyword>
	<keyword>childhood oligodendroglioma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>recurrent childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult supratentorial primitive neuroectodermal tumor ( PNET )</keyword>
</DOC>